HB 1576: Medicaid; terms; Oklahoma Health Care Authority; coverage; Medicaid; criteria; medical necessity; discretion; Chief Operating Officer; Health Information Portability and Accountability Act; scientific research; consent; research; opting-out; minors; promulgation of rules and regulations; waiver application; effective date; emergency. - Oklahoma

Floor (House) → Floor (Senate) · 5 edits

MODERATE

The bill was amended to transition from the House version to the Senate floor version, which includes substantive changes to the definition of rapid whole genome sequencing, expanded medical necessity criteria for coverage, and additional provisions for genetic data use in research. These changes clarify eligibility requirements and expand the conditions under which Medicaid will cover this advanced genetic testing service.

Scope change

The bill's scope was expanded to include patient-only whole genome sequencing and duo/trio whole genome sequencing of patients with biological parents, and added specific medical conditions that qualify for coverage.

DEFINITION

Definition of rapid whole genome sequencing was expanded to explicitly include patient-only whole genome sequencing and duo/trio whole genome sequencing of the patient and biological parent or parents.

ELIGIBILITY

Added specific medical conditions that qualify for coverage including congenital anomalies involving at least two organ systems, complex metabolic disorders, abnormal laboratory tests suggesting genetic disease, and severe muscle weakness or rigidity.

REQUIREMENT

Added provisions allowing genetic data generated from covered testing to be used in scientific research if consent is given by the patient or legal guardian.

Added provisions allowing patients or their legal guardians to rescind original consent to the use of genetic data.

ENFORCEMENT

Added authority for the Chief Operating Officer of the Oklahoma Health Care Authority to add additional conditions based on new medical evidence or provide coverage for other next generation sequencing and genetic testing beyond what is required.

Enrolled (final version) → Floor (House) · 3 edits

MINOR

The bill was reformatted from an enrolled version to a floor version for the House, with line numbers and page headers added. The substantive policy content regarding Medicaid coverage for rapid whole genome sequencing remains unchanged, though the formatting was adjusted to reflect the floor version of the bill.

TECHNICAL

Bill was reformatted from enrolled version to floor version with added line numbers, page headers, and committee amendment markers.

Header text changed from 'ENROLLED HOUSE BILL' to 'HOUSE OF REPRESENTATIVES - FLOOR VERSION' with updated legislative session information.

Page headers were added with bill number, page numbers, and notes indicating bold face denotes committee amendments.

Engrossed → Enrolled (final version) · 4 edits · May 22, 2025

MODERATE

The bill was converted from an Engrossed version to an Enrolled final version, adding a detailed summary of the bill's purpose and introducing a new subsection (G) that authorizes the Chief Operating Officer of the Oklahoma Health Care Authority to promulgate rules and submit waiver applications to CMS. The substantive policy provisions regarding rapid whole genome sequencing coverage for Medicaid beneficiaries under 21 with complex illnesses remain unchanged.

Scope change

The bill's scope remains the same - it covers rapid whole genome sequencing for Medicaid beneficiaries under 21 with complex or acute illnesses of unknown etiology. The Enrolled version adds administrative authority for rulemaking and waiver applications.

REQUIREMENT

New subsection G authorizes the Chief Operating Officer of the Oklahoma Health Care Authority to take necessary actions including promulgating rules and regulations for Medicaid coverage and submitting waiver applications to CMS

TECHNICAL

Added a detailed summary statement describing the bill's purpose and provisions

Changed bill header from 'ENGROSSED HOUSE' to 'ENROLLED HOUSE' and updated sponsor names to include Cantrell and Williams

Reorganized formatting and page numbering from the Enrolled version

Amended And Engrossed → Engrossed · 4 edits · May 22, 2025

MODERATE

The bill was amended to remove the emergency designation and update formatting, while adding new provisions allowing genetic data from rapid whole genome sequencing to be used in scientific research with patient consent, and clarifying patient rights to access results and revoke research consent.

Scope change

The bill's scope expanded to explicitly include scientific research use of genetic data, previously not addressed in the original version.

TIMELINE

Removed the emergency designation that would have expedited the bill's effective date.

REQUIREMENT

Added new Section F allowing genetic data to be used in scientific research if consent is expressly given by the patient or legal guardian.

Added patient rights to access test results for use in other clinical settings and to revoke research consent at any time.

TECHNICAL

Updated formatting and spacing throughout the document to align with standard legislative formatting.

Introduced → Amended And Engrossed · 4 edits · May 22, 2025

MODERATE

The bill was amended to change its title and format to reflect an Engrossed Senate Amendment, while the substantive policy text regarding Medicaid coverage for rapid whole genome sequencing remains largely unchanged. The amendment primarily updates the document's header information and reorganizes the presentation of the bill without altering the core medical coverage requirements or eligibility criteria.

Scope change

The bill's scope and applicability remain unchanged; the amendment is primarily procedural and formatting-related.

TECHNICAL

Document title changed from 'Introduced' to 'Engrossed Senate Amendment' to reflect the legislative process stage.

Header information updated to show the bill was passed by the Senate and is now being processed by the House of Representatives.

Page numbering and formatting were adjusted to align with standard legislative amendment procedures.

SCOPE

The substantive text regarding Medicaid coverage for rapid whole genome sequencing, eligibility criteria, and HIPAA requirements remains the same.

What changed between versions

How they voted

Actions timeline

Sponsors